- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07467616
Impact of Clinical Nursing Guideline on Outcomes of Children With Diabetic Ketoacidosis. (PED-DKA)
Impact of an Evidence-Based Practice Nursing Guideline on Clinical Outcomes in Children With Diabetic Ketoacidosis: A Quasi-Experimental Study
Diabetic ketoacidosis (DKA) is a serious and potentially life-threatening complication of diabetes mellitus in children and requires timely and structured management to prevent morbidity and mortality. Inconsistency in clinical practice and delayed recognition of complications may negatively affect patient outcomes. Evidence-based clinical nursing guidelines can improve the quality and consistency of care provided to children with DKA.
This study aimed to assess the impact of an evidence-based nursing guideline on clinical outcomes among children diagnosed with diabetic ketoacidosis. A quasi-experimental study design was used, including two groups: a control group receiving routine hospital care and an intervention group receiving care based on an evidence-based nursing guideline.
The guideline included structured nursing assessment, continuous monitoring of vital signs and neurological status, blood glucose monitoring, fluid balance monitoring, and early detection and management of complications. Clinical outcomes including blood glucose level, blood pH, neurological status, and duration of hospital stay were compared between the control and intervention groups.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Diabetic ketoacidosis is one of the most common acute complications of diabetes mellitus in pediatric patients and remains a major cause of morbidity and hospital admission among children with diabetes. Effective management requires careful monitoring of metabolic status, fluid therapy, insulin administration, and early detection of complications such as cerebral edema and electrolyte imbalance.
Evidence-based nursing practice plays an essential role in improving the quality of care and patient safety during the management of pediatric diabetic ketoacidosis. Implementation of standardized clinical nursing guidelines can enhance clinical decision-making, improve monitoring of patients, and promote early identification of complications.
This study was conducted to assess the effectiveness of implementing an evidence-based clinical nursing guideline on clinical outcomes among children diagnosed with diabetic ketoacidosis. A quasi-experimental study design was used. Children admitted with diabetic ketoacidosis were divided into a control group receiving routine hospital management and an intervention group receiving care according to an evidence-based nursing guideline.
The guideline included structured monitoring of vital signs, neurological assessment using the Glasgow Coma Scale, frequent blood glucose monitoring, fluid balance monitoring, electrolyte monitoring, and nursing interventions aimed at early detection and prevention of complications.
Clinical outcomes evaluated in this study included blood glucose level, blood pH level, neurological status, and length of hospital stay. The findings of this study are expected to provide evidence regarding the effectiveness of structured nursing guidelines in improving the management and clinical outcomes of pediatric patients with diabetic ketoacidosis.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Kurdistan Region
-
Erbil, Kurdistan Region, Iraq, 44001
- Raparin Pediatric Teaching Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Children age from 6-16 years old.
- Both sexes.
- Have not other critical medical condition that interfere with study.
- Diagnosed with diabetic ketoacidosis.
- Have the ability to participate and accept to participate in the study.
Exclusion Criteria:
- Children with comorbid chronic illnesses like congenital heart disease, renal failure, etc.
- Recurrent admission during the same study period (only first admission considered).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control Group
Children with diabetic ketoacidosis who received routine hospital management according to standard hospital protocol without implementation of the evidence-based nursing guideline.
|
|
|
Other: Intervention Group
Children with diabetic ketoacidosis who received care according to an evidence-based clinical nursing guideline including structured monitoring of vital signs, neurological assessment, blood glucose monitoring, fluid balance monitoring, and early detection and management of complications.
|
Implementation of an evidence-based clinical nursing guideline for the management of children with diabetic ketoacidosis.
The guideline includes structured nursing assessment, continuous monitoring of vital signs and neurological status using the Glasgow Coma Scale, frequent blood glucose monitoring, fluid balance monitoring, electrolyte monitoring, and nursing interventions aimed at early detection and management of complications during DKA treatment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Resolution Time of Diabetic ketoacidosis
Time Frame: From the time of hospital admission until normalization of metabolic parameters indicating resolution of diabetic ketoacidosis, assessed up to 48 hours.
|
Time required for resolution of diabetic ketoacidosis measured from hospital admission until normalization of metabolic parameters including blood glucose level, blood pH, and serum bicarbonate according to standard pediatric DKA management criteria.
|
From the time of hospital admission until normalization of metabolic parameters indicating resolution of diabetic ketoacidosis, assessed up to 48 hours.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood glucose level
Time Frame: From hospital admission to 48 hours after initiation of treatment
|
Change in blood glucose level during treatment of DKA, unitl return to normal standard level.
|
From hospital admission to 48 hours after initiation of treatment
|
|
Length of hospital stay
Time Frame: From hospital admission until hospital discharge, with follow-up assessment conducted up to 2 months after discharge
|
Total duration of hospital stay measured in days from admission until discharge of child to home.
|
From hospital admission until hospital discharge, with follow-up assessment conducted up to 2 months after discharge
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Khaleed M Shaikhah, MSc, Hawler Medical University/ College of Nursing
Publications and helpful links
General Publications
- Wright, N., & Thomas, R. (2021). BSPED guideline: what we know and why the guideline was changed. Archives of Disease in Childhood-Education and Practice, 106(4), 226-228.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PED-DKA-GUIDELINE-2026
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetic Ketoacidosis
-
Universiti Sains MalaysiaRecruitingTreatment Diabetic Ketoacidosis, Electrolyte Balance EffectsMalaysia
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Unknown
-
Indigo Diabetes NVCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus | Hypoglycemia | Diabetes Mellitus, Type 1 | Ketoacidosis, Diabetic | Hyperglycaemia (Diabetic)Belgium, Slovenia, France
-
University Hospital, MontpellierCompletedDiabetic Ketoacidosis ChildrenFrance
-
Centre Hospitalier Universitaire de NiceRecruiting
-
Aydin Adnan Menderes UniversityActive, not recruitingChild | Pediatrics | Ketoacidosis, Diabetic | Diabete Type 1Turkey (Türkiye)
-
State University of New York at BuffaloTerminatedDiabetic KetoacidosisUnited States
-
Marshall UniversityCompletedDiabetic KetoacidosisUnited States
Clinical Trials on Evidence-Based Nursing Guideline for Children with Diabetic Ketoacidosos
-
Hacettepe UniversityCompletedImplantable Cardioverter-defibrillators (ICDs)Turkey (Türkiye)
-
Cairo UniversityCompletedNursing Caries | Competence | Practice Nurse's ScopeEgypt
-
Haiyan PanRecruiting
-
Sabri HergünerCompletedAutism Spectrum DisorderTurkey
-
Denver Health and Hospital AuthorityCompleted
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Yale University; AstraZenecaRecruitingHeart Failure With Reduced Ejection FractionNetherlands
-
Göteborg UniversityForte; Medtanken Group AB; FoU i Västra GötalandsregionenCompletedQuality of Life | Stress | Parent-Child Relations | Parenting | Behavior, ChildSweden
-
University of California, Los AngelesVirginia Commonwealth University; United States Naval Medical Center, San Diego and other collaboratorsRecruiting
-
Chinese University of Hong KongCompletedParent-Child Relations | Autism Spectrum DisorderHong Kong
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingSevere Poisoning With Cardiotropic or Psychotropic Drug | Admission to Intensive CareFrance